BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17325964)

  • 1. Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?
    Franchini M
    Hematology; 2006 Jun; 11(3):209-13. PubMed ID: 17325964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV and HCV coinfection].
    Ruiz-Sancho A; Soriano V
    Enferm Infecc Microbiol Clin; 2006 May; 24(5):335-45; quiz 346. PubMed ID: 16762261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.
    D'Offizi G; Martini F; Rozera G; Abbate I; Capobianchi MR; Narciso P; Dianzani F
    AIDS; 2008 Jan; 22(2):321. PubMed ID: 18097242
    [No Abstract]   [Full Text] [Related]  

  • 4. HBV plus HCV, HCV plus HIV, HBV plus HIV.
    Park JS; Saraf N; Dieterich DT
    Curr Gastroenterol Rep; 2006 Feb; 8(1):67-74. PubMed ID: 16510037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatitis C in HIV infected and other immunocompromised individuals.
    Seth AK
    Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delaying HCV treatment in HIV-positive patients.
    Carter M
    IAPAC Mon; 2005 May; 11(5):147. PubMed ID: 16201045
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hepatitis C virus infection in patients with concurrent human immunodeficiency virus infection].
    Peters L; Lindhardt BØ
    Ugeskr Laeger; 2006 Oct; 168(42):3604-8. PubMed ID: 17069721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological, clinical and therapeutical aspects of HIV/HCV coinfection in a series of HIV seropositive Umbrian patients].
    Francisci D; Valente M; Di Candilo F; Sfara C; Conte ME; Canovari B; Baldelli F; Stagni G
    Recenti Prog Med; 2004 Nov; 95(11):521-4. PubMed ID: 15598089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus: a paired liver biopsy study.
    Rodríguez-Torres M; Rodríguez-Orengo JF; Ríos-Bedoya CF; Fernández-Carbia A; Marxuach-Cuétara AM; López-Torres A; Jiménez-Rivera J
    J Hepatol; 2007 Apr; 46(4):613-9. PubMed ID: 17316873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hepatitis C virus coinfection in HIV-infected persons.
    O'Leary JG; Chung RT
    AIDS Read; 2006 Jun; 16(6):313-6, 318-20. PubMed ID: 16795921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapy.
    Reiberger T; Kosi L; Maresch J; Breitenecker F; Payer BA; Wrba F; Rieger A; Gangl A; Peck-Radosavljevic M
    J Infect Dis; 2010 Jul; 202(1):156-60. PubMed ID: 20486858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Eradication of HCV on Hepatic Venous Pressure Gradient in HIV-Infected Patients With Compensated HCV-Related Cirrhosis.
    Sánchez-Conde M; Pérez-Latorre L; Rincón D; Miralles P; Catalina MV; López JC; Bañares R; Berenguer J
    J Acquir Immune Defic Syndr; 2015 Aug; 69(4):e142-4. PubMed ID: 25861016
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving anti-hepatitis C virus therapy.
    Pol S; Mallet VO
    Expert Opin Biol Ther; 2006 Sep; 6(9):923-33. PubMed ID: 16918259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/HCV coinfection in clinical practice.
    Dieterich DT; Kontorinis N; Agarwal K
    J Int Assoc Physicians AIDS Care (Chic); 2004 Oct; 3 Suppl 1():S4-14; quiz S16-7. PubMed ID: 15566014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection.
    Hornberger J; Torriani FJ; Dieterich DT; Bräu N; Sulkowski MS; Torres MR; Green J; Patel K
    J Clin Virol; 2006 Aug; 36(4):283-91. PubMed ID: 16765638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New paradigms in the management of hepatitis C virus co-infections.
    Sherman KE
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jan; 4 Suppl 1():S10-6. PubMed ID: 17235280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hepatitis C virus in HIV-positive patients].
    Mallolas Masferrer J; Martínez-Rebollar M; Laguno Centeno M
    Gastroenterol Hepatol; 2011 Oct; 34(8):558-67. PubMed ID: 21435743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office.
    Tien PC; ;
    Am J Gastroenterol; 2005 Oct; 100(10):2338-54. PubMed ID: 16181388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapy.
    De Bona A; Galli L; Gallotta G; Guzzo A; Alagna L; Lazzarin A; Uberti-Foppa C
    New Microbiol; 2007 Jul; 30(3):259-64. PubMed ID: 17802905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV & hepatitis C: treatment.
    WORLD; 2002 May; (133):4-5. PubMed ID: 12064298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.